The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 311.00
Bid: 311.00
Ask: 311.80
Change: -2.40 (-0.77%)
Spread: 0.80 (0.257%)
Open: 314.00
High: 315.00
Low: 309.20
Prev. Close: 313.40
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase programme

26 Feb 2020 10:01

RNS Number : 1893E
Ascential PLC
26 February 2020
 

 

 

 

26 February 2020

 

 

Ascential plc ("the Company")

Share repurchase programme

 

Pursuant to the authority granted at the Annual General Meeting of the Company held on 8 May 2019, the Company announces it entered into a non-discretionary agreement with Numis Securities Limited ("Numis") on 25 February 2020 in relation to the purchase by Numis, acting as principal, of the Company's ordinary shares of 1 pence each ("Ordinary Shares") for an aggregate purchase price of up to £120m (the "Programme") and not exceeding 40,277,568 ordinary shares of 0.01p each, representing approximately 9.99% per cent. of its current issued ordinary share capital.

The Company commenced the buyback programme on Tuesday 25 February 2020.

Any purchase of shares done in relation to this announcement will be carried out on the London Stock Exchange and will be effected within certain pre-set parameters.

Ascential's shareholders generally authorised Ascential to purchase Ordinary Shares at its 2019 Annual General Meeting held on 8 May 2019, subject to certain limitations (the "Authority"). The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the Authority. The Programme will be executed in accordance with (and subject to the limits prescribed by) the Authority and will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and in accordance with Chapter 12 of the Listing Rules.

The Company will announce any market repurchase of shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. The purpose of the Programme is to reduce the share capital of the Company. All Shares purchased will be cancelled.

The total number of voting rights in the Company on 25 February 2020 was 403,274,977.

 

Name and contact details for enquiries:

Louise Meads, Company Secretary +44 (0) 20 7516 5042

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSTFMLTMTATMPM
Date   Source Headline
22nd Apr 20243:39 pmRNSResults of General Meeting
18th Apr 20246:14 pmRNSDirector/PDMR Shareholding
11th Apr 202410:12 amRNSHolding(s) in Company
10th Apr 20241:48 pmRNSHolding(s) in Company
10th Apr 202410:32 amRNSNotice of AGM
9th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 20245:09 pmRNSHolding(s) in Company
5th Apr 20243:18 pmRNSHolding(s) in Company
4th Apr 20241:45 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSProposed Return of Value of £850m to Shareholders
3rd Apr 202410:39 amRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSHolding(s) in Company
2nd Apr 202412:00 pmRNSTotal Voting Rights
28th Mar 20242:25 pmRNSHolding(s) in Company
28th Mar 202411:33 amRNSHolding(s) in Company
27th Mar 202412:02 pmRNSHolding(s) in Company
26th Mar 202412:16 pmRNSHolding(s) in Company
25th Mar 20243:40 pmRNSHolding(s) in Company
25th Mar 20242:26 pmRNSHolding(s) in Company
22nd Mar 20242:20 pmRNSHolding(s) in Company
21st Mar 20243:38 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSUnaudited full year results 2023
13th Mar 20244:49 pmRNSHolding(s) in Company
12th Mar 20241:24 pmRNSHolding(s) in Company
1st Mar 20242:25 pmRNSTotal Voting Rights
29th Feb 202410:22 amRNSHolding(s) in Company - Correction
27th Feb 20241:12 pmRNSHolding(s) in Company
22nd Feb 20245:01 pmRNSHolding(s) in Company
20th Feb 20241:26 pmRNSHolding(s) in Company
16th Feb 20241:06 pmRNSHolding(s) in Company
15th Feb 20244:08 pmRNSHolding(s) in Company
7th Feb 20243:40 pmRNSHolding(s) in Company
6th Feb 20244:06 pmRNSTotal Voting Rights
6th Feb 20241:41 pmRNSHolding(s) in Company
5th Feb 20241:05 pmRNSHolding(s) in Company
1st Feb 20242:48 pmRNSCompany Secretary Change
1st Feb 202411:35 amRNSCompletion of the sale of WGSN
5th Jan 20242:52 pmRNSBlock listing Interim Review
5th Jan 20247:49 amRNSDirector/PDMR Shareholding
4th Jan 202412:53 pmRNSHolding(s) in Company
2nd Jan 202411:21 amRNSUpdate on Sale Processes, Governance and Financing
29th Dec 202310:00 amRNSDirector/PDMR Shareholding
18th Dec 202310:10 amRNSResults of General Meeting
1st Dec 202312:28 pmRNSPublication of Circular and Notice of General Mtg
27th Nov 202310:31 amRNSDirector/PDMR Shareholding
22nd Nov 202312:03 pmRNSHolding(s) in Company
16th Nov 202311:57 amRNSHolding(s) in Company
6th Nov 20232:46 pmRNSHolding(s) in Company
6th Nov 202312:22 pmRNSHolding(s) in Company
3rd Nov 20232:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.